The Rheumatologist
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
  • Technology
    • Electronic Health Records
    • Apps
    • Information Technology
  • Resources
    • Issue Archives
    • Events
    • Multimedia
      • Audio
      • Video
    • From the College
    • American College of Rheumatology
    • Rheumatology Research Foundation
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • Treatment Guidelines
    • Research Reviews
    • Annual Meeting
      • Abstracts
      • Meeting Reports
    • Rheumatology Image Bank
    • ACR ExamRheum
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Opioids No Better Than NSAIDs for Chronic Back or Arthritis Pain

Opioids No Better Than NSAIDs for Chronic Back or Arthritis Pain

March 7, 2018 • By Lisa Rapaport

  • Tweet
  • Email
Print-Friendly Version / Save PDF

(Reuters Health)—Acetaminophen, ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs) are better than opioids at easing the intensity of chronic pain in the back, knees or hips, a U.S. experiment suggests.

You Might Also Like
  • Nonopioid Medication May Be as Effective as Opioids for Chronic Pain
  • U.S. Agency Issues New Guidelines to Limit Chronic Use of Opioids
  • Lilly Says New Type of Pain Drug Could Reduce Need for Opioids

And opioids are no better than these other drugs at reducing how much pain interferes with daily activities, such as walking, working, sleeping or enjoying life, researchers report in JAMA, online March 6.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“We already knew opioids were more dangerous than other treatment options, because they put people at risk for accidental death and addiction,” says lead study author Dr. Erin Krebs of the Minneapolis VA Health Care System and the University of Minnesota.

“This study shows that extra risk doesn’t come with any extra benefit,” Krebs says by email.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

U.S. deaths from opioids, including heroin and such prescription drugs as oxycodone, hydrocodone and methadone, have more than quadrupled since 1999, according to the Centers for Disease Control and Prevention (CDC) in Atlanta. Today, more than six in 10 drug overdose deaths involve opioids.

Amid this worsening opioid crisis, the CDC has urged physicians to use opioids only as a last resort. Instead, doctors should talk to patients about the potential for exercise or physical therapy to help ease symptoms and prescribe other, less addictive drugs for pain, including acetaminophen (Tylenol) and such NSAIDS as aspirin, ibuprofen (Advil, Motrin) and naproxen (Aleve).

NSAIDs carry their own risks, especially at high doses, including the potential for internal bleeding, kidney damage and heart attacks. But they aren’t addictive.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

For the current study, researchers randomly assigned 240 patients seeking pain treatment at VA primary care clinics to receive either opioids or alternative medicines like acetaminophen or ibuprofen for one year.

Participants were 58 years old on average and most were men. Back pain was their most common complaint, affecting 156 patients, or 65%, and the rest had either hip or knee osteoarthritis pain.

People in the opioid group started therapy with fast-acting morphine, a combination of hydrocodone and acetaminophen, or immediate release oxycodone. If that wasn’t successful, patients next got long-acting morphine or oxycodone, and then doctors tried fentanyl patches.

In the non-opioid group, patients first got acetaminophen and NSAIDs. If those options didn’t help enough, doctors tried options, such as the nerve pain drug gabapentin (Neurontin) and topical painkillers like lidocaine, followed by the nerve pain drug pregabalin (Lyrica) and tramadol, an opiate painkiller.

Researchers asked participants to rate how much pain interfered with their lives at the start of the study, and again 12 months later.

Pages: 1 2 | Single Page

Filed Under: Analgesics, Drug Updates Tagged With: Chronic pain, hip, hip pain, Knee Osteoarthritis (OA), Nonsteroidal anti-inflammatory drugs (NSAIDs), NSAIDs, Opioids, osteoarthritis (OA), Pain, Pain Management

You Might Also Like:
  • Nonopioid Medication May Be as Effective as Opioids for Chronic Pain
  • U.S. Agency Issues New Guidelines to Limit Chronic Use of Opioids
  • Lilly Says New Type of Pain Drug Could Reduce Need for Opioids
  • Medical Cannabis Helps Chronic Pain Patients Cut Opioid Use

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR/ARP Meeting Abstracts

Browse and search abstracts from the ACR/ARP Annual Meetings going back to 2012.

Visit the ACR/ARP Meeting Abstracts site »

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2019 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.